Evidence map›Paper›PMID 11116151›Full record

ArticleThe Journal of biological chemistry2001

Polypyrimidine track-binding protein binding downstream of caspase-2 alternative exon 9 represses its inclusion.

J Côté, S Dupuis, J Y Wu

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J CôtéDepartment of Pediatrics and Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
S Dupuis
J Y Wu
Washington University in St. Louis · US

Funding

Pre-mRNA Splicing Defects and Retinal DegenerationR01EY014576 · NEI · VANDERBILT UNIVERSITY · PI WU, JANE Y · 2004 to 2008
$1.8M
Slit Signaling in Breast CancerR01CA114197 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WU, JANE Y · 2006 to 2010
$1.3M
Alternative splicing regulation of caspase-2 geneR01GM070967 · NIGMS · VANDERBILT UNIVERSITY · PI WU, JANE Y · 2005 to 2008
$939k
NCI NIH HHS R01 CA114197NEI NIH HHS R01 EY014576NIGMS NIH HHS R01 GM070967
6 · The paper itself

Abstract

We have been using the caspase-2 pre-mRNA as a model system to study the importance of alternative splicing in the regulation of programmed cell death. Inclusion or skipping of a cassette-type exon in the 3' portion of this pre-mRNA leads to the production of isoforms with antagonistic activity in apoptosis. We previously identified a negative regulatory element (In100) located in the intron downstream of alternative exon 9. The upstream portion of this element harbors a decoy 3' acceptor site that engages in nonproductive commitment complex interactions with the 5' splice site of exon 9. This in turn confers a competitive advantage to the exon-skipping splicing pattern. Further characterization of the In100 element reveals a second, functionally distinct, domain located downstream from the decoy 3' acceptor site. This downstream domain harbors several polypyrimidine track-binding protein (PTB)-binding sites. We show that PTB binding to these sites correlates with the negative effect on exon 9 inclusion. Finally, we show that both domains of the In100 element can function independently to repress exon 9 inclusion, although PTB binding in the vicinity of the decoy 3' splice site can modulate its activity. Our results thus reveal a complex composite element that regulates caspase-2 exon 9 alternative splicing through a novel mechanism.

Indexed as

Alternative SplicingExonsBase SequenceBinding SitesCaspase 2CaspasesHeLa CellsHeterogeneous-Nuclear RibonucleoproteinsHumansMolecular Sequence DataPolypyrimidine Tract-Binding ProteinRibonucleoproteinsRNA-Binding ProteinsCaspase 2CaspasesHeterogeneous-Nuclear RibonucleoproteinsPolypyrimidine Tract-Binding ProteinRibonucleoproteinsRNA-Binding Proteins

Identifiers

PMID11116151
PMCPMC2140227
OpenAlexW2063642745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.